Moreover, under certain conditions, alternative activation of KCs by IL-4/IL-13 has been found to ameliorate obesity-induced insulin resistance by regulating PPARδ [19,69], suggesting a beneficial role for M2-activated KCs in metabolic syndrome and NAFLD. This evidence concerns the gene TBCE and metabolic syndrome.